Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamivudine vs Entecavir in Severe Acute Exacerbation of Chronic Hepatitis B
NCT01627223Phase 4Terminated
- Sponsor
- Taichung Veterans General Hospital
- Start
- Jul 2012
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lamivudine, entecavir in Chronic Hepatitis B (CHB), sponsored by Taichung Veterans General Hospital. Started Jul 2012; status: terminated.
02
Drugs
lamivudineentecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01627223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01627223.